盖莱克:糖尿病和糖尿病足的作用和治疗方法
Alhasan Alobaidi1, Rawan Al Judeid2, Vikrant Rai1
1Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Biomolecules
|February 27, 2026
概括
加勒,特别是加勒-3,与糖尿病并发症有关,例如血管损伤和伤口愈合不良. 向胆素显示出治疗糖尿病及其相关问题的前景.
科学领域:
- 内分泌学和新陈代谢学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 糖尿病是一种慢性炎症性疾病,其特点是高血糖,导致广泛的并发症.
- 这些并发症,包括心血管疾病,病和神经病变,源于血管和神经的损伤.
- 碳水化合物结合蛋白的家族 - - 盖莱克因其在糖尿病相关的炎症和纤维化过程中的作用而越来越被认可.
研究的目的:
- 审查目前对糖尿病中加列生物学的理解,重点关注II型糖尿病.
- 阐明加勒在代谢功能障碍和受损伤愈合中的机制性作用.
- 评估针对糖尿病及其并发症,特别是糖尿病足 (DFU) 的向加勒的治疗和诊断潜力.
主要方法:
- 广泛的文献搜索和现有证据的综合.
- 分析临床前和人类研究的分析,调查加勒在糖尿病病变发生过程中的参与.
- 评估目前和新兴的诊断和治疗策略,以标为目标.
主要成果:
- 加勒,特别是加勒-3,对糖尿病并发症的发病有显著的贡献.
- 这些蛋白质促进炎症,纤维化和血管损伤,加剧代谢功能障碍并阻碍伤口愈合.
- 有证据表明,加勒在糖尿病足的发展中起着至关重要的作用.
结论:
- 黄素在糖尿病及其相关并发症的发展和进展中起着关键作用.
- 向甲状腺素是治疗糖尿病及其后果的一个有前途的治疗途径.
- 需要进一步的研究来弥合前临床发现和临床翻译之间的差距,以加勒为基础的疗法.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
672
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
672
01:05Proteoglycans
5.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.0K
01:27Glucose Transporters
27.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
01:24Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K